Published in J Virol Methods on January 01, 2000
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol (2005) 7.91
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol (2001) 0.76
Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev (1994) 4.95
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol (2004) 4.12
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Cloned pigs produced by nuclear transfer from adult somatic cells. Nature (2000) 3.51
Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77
Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses (1993) 2.29
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
Indoor moulds and asthma. J R Soc Health (1988) 2.19
Sources and incidence of airborne Aspergillus fumigatus (Fres). Clin Allergy (1976) 2.17
Asthma admissions and thunderstorms: a study of pollen, fungal spores, rainfall, and ozone. QJM (2001) 2.10
B-cell subpopulations identified by two-colour fluorescence analysis. Nature (1982) 2.06
Protozoa as sources of antigen in 'humidifier fever'. Nature (1976) 2.06
Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis (1993) 1.95
Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol Reprod (2003) 1.91
A comparison of noncontrast computerized tomography with excretory urography in the assessment of acute flank pain. J Urol (1999) 1.85
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol (1998) 1.79
Fungal spores in lung and sputum. Clin Allergy (1978) 1.55
Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses (2008) 1.46
Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol (1997) 1.38
Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest (1996) 1.32
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine (1994) 1.31
Regional variations in grass pollen seasons in the UK, long-term trends and forecast models. Clin Exp Allergy (1999) 1.28
Relationships between airborne fungal spore concentration of Cladosporium and the summer climate at two sites in Britain. Int J Biometeorol (2003) 1.20
Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15
Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment. Virology (2001) 1.12
AIDS vaccine developments. Nature (1992) 1.11
The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol (1993) 1.10
The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. Endocrinology (1992) 1.08
A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study. Antibiot Chemother (1971) (1996) 1.05
Long terminal repeat U3 length polymorphism of human foamy virus. Virology (1997) 1.04
Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model. Kidney Int (1992) 1.03
Mouse model to study the replication of primate foamy viruses. J Gen Virol (1997) 1.00
Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retroviruses (1994) 1.00
Gene trap integrations expressed in the developing heart: insertion site affects splicing of the PT1-ATG vector. Dev Dyn (1998) 0.99
B-cell subpopulations identifiable by two-color fluorescence analysis using a dual-laser FACS. Ann N Y Acad Sci (1982) 0.98
Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med (1994) 0.98
Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology (1997) 0.96
Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. J Med Primatol (2001) 0.96
The neurula stage mouse embryo in control of neuroblastoma. Proc Natl Acad Sci U S A (1984) 0.95
Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques. J Med Primatol (1995) 0.95
Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS (2001) 0.95
Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype. Leukemia (2000) 0.93
The interleukin-17 gene of herpesvirus saimiri. J Virol (1998) 0.92
Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunol Lett (1996) 0.92
Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination. J Gen Virol (1995) 0.92
Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Allergy (1993) 0.91
Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys. J Infect Dis (1995) 0.90
Prevention of human immunodeficiency virus infection among intravenous drug users in New South Wales, Australia: the needles and syringes distribution programme through retail pharmacies. Asia Pac J Public Health (1988) 0.90
Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol (1997) 0.89
Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques. Intervirology (1996) 0.88
Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV. J Neurovirol (2000) 0.87
Mucosal exposure to subinfectious doses of SIV primes gut-associated antibody-secreting cells and T cells: lack of enhancement by nonneutralizing antibody. Virology (2001) 0.87
The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques. J Gen Virol (2000) 0.85
Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol (1996) 0.85
An outbreak of disseminated aspergillosis associated with an intensive care unit. Community Med (1988) 0.85
Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques. Eur J Immunol (1999) 0.85
Aspergillus fumigatus spore concentration in outside air: Cardiff and St Louis compared. Clin Allergy (1984) 0.85
Micro-endoscope for in vivo widefield high spatial resolution fluorescent imaging. Biomed Opt Express (2012) 0.84
T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology. J Virol (1998) 0.84
Virologic and serologic characteristics of a natural chimpanzee lentivirus infection. Virology (1995) 0.84
Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees. J Med Primatol (2001) 0.84
Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally. J Med Virol (2001) 0.83
An in vivo model for HIV resistance development. AIDS Res Hum Retroviruses (2001) 0.83
Different proliferative response of human and chimpanzee lymphocytes after contact with human immunodeficiency virus type 1 gp120. Eur J Immunol (1994) 0.83
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines. J Med Primatol (1992) 0.83
Comparative analysis of apoptosis in HIV-infected humans and chimpanzees: relation with lymphocyte activation. Immunol Lett (1996) 0.82
Mucosal function after ileal mucosal fenestration and colonic autotransplantation. Br J Surg (1991) 0.82
Transgenic rats: new animal models in hypertension research. Invited lecture. Hypertension (1991) 0.81
The increase in hay fever: pollen, particulate matter and SO2 in ambient air. QJM (1996) 0.80
Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization. Neurosci Lett (1990) 0.79
Characterization of the ovine LH beta-subunit gene: the promoter is regulated by GnRH and gonadal steroids in transgenic mice. J Endocrinol (1996) 0.79
Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. Vaccine (1994) 0.79
Occupational asthma in tomato growers following an outbreak of the fungus Verticillium albo-atrum in the crop. J Soc Occup Med (1988) 0.79
The morphology and pathogenesis of magnesium deficiency-induced nephrocalcinosis. Exp Mol Pathol (1980) 0.79
Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys. J Gen Virol (2001) 0.79
Proteomic analysis of epidermal mucus from sea lice-infected Atlantic salmon, Salmo salar L. J Fish Dis (2013) 0.78
Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 protein. Acta Gastroenterol Belg (2000) 0.77
Antibody-dependent cellular cytotoxicity to clinical isolates of HIV-1 and SIVcpz: comparison of human and chimpanzees. AIDS (1996) 0.77
Type-C oncovirus isolate from human leukemic bone marrow: further in vitro and in vivo characterization. Int J Cancer (1978) 0.77
Differential cytotoxic T-lymphocyte (CTL) responses in HIV-1 immunised sibling chimpanzees with shared MHC haplotypes. Immunol Lett (1999) 0.77
City spore concentrations in the European Economic Community (EEC). VII. Oleaceae (Fraxinus, Ligustrum, Olea). Clin Allergy (1988) 0.77
Effect of freezing semen and dosage of sperm on number of accessory sperm, fertility, and embryo quality in artificially inseminated cattle. J Anim Sci (1993) 0.77
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeys. J Med Primatol (2001) 0.77
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol (2001) 0.76
Grass pollen content of the air in the Bristol Channel region in 1976. Clin Allergy (1977) 0.76
Using rapidly alternating multiple schedules to assess and treat aberrant behavior in natural settings. Behav Modif (1999) 0.76
The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors. J Hum Hypertens (1989) 0.76
Lipopolysaccharide and silica-stimulated mononuclear cell prostaglandin production in ulcerative colitis. Mediators Inflamm (2000) 0.75
Grass pollen concentrations in the U.K. J R Soc Health (1983) 0.75
The Southwest Oncology Group experience: adjuvant therapy for stage IB and II non-seminomatous testicular cancer. Int J Radiat Oncol Biol Phys (1983) 0.75
Prick skin testing for aspergillus. Clin Allergy (1982) 0.75
Use of a density gradient column in the analysis of urinary calculi. Invest Urol (1981) 0.75
Circadian periodicity of grass pollen. Ann Allergy (1986) 0.75
Transgenic approaches to modification of cell and tissue function. Curr Opin Cell Biol (1991) 0.75
Diagnostic value of surgical testicular biopsy after therapy for acute lymphocytic leukemia. J Pediatr (1985) 0.75